-
Something wrong with this record ?
Protective Effects of Resveratrol Against Airway Hyperreactivity, Oxidative Stress, and Lung Inflammation in a Rat Pup Model of Bronchopulmonary Dysplasia
R. Reçica, I. Kryeziu, Q. Thaçi, D. Avtanski, M. Mladenov, M. Basholli-Salihu, RB. Sopi
Status minimal Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
- MeSH
- Antioxidants pharmacology MeSH
- Bronchial Hyperreactivity prevention & control metabolism physiopathology chemically induced MeSH
- Bronchopulmonary Dysplasia * prevention & control metabolism MeSH
- Hyperoxia complications metabolism MeSH
- Rats MeSH
- Disease Models, Animal * MeSH
- Animals, Newborn * MeSH
- Oxidative Stress * drug effects MeSH
- Pneumonia * prevention & control metabolism chemically induced MeSH
- Rats, Sprague-Dawley MeSH
- Resveratrol * pharmacology MeSH
- Stilbenes pharmacology therapeutic use MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Oxygen therapy provides an important treatment for preterm and low-birth-weight neonates, however, it has been shown that prolonged exposure to high levels of oxygen (hyperoxia) is one of the factors contributing to the development of bronchopulmonary dysplasia (BPD) by inducing lung injury and airway hyperreactivity. There is no effective therapy against the adverse effects of hyperoxia. Therefore, this study was undertaken to test the hypothesis that natural phytoalexin resveratrol will overcome hyperoxia-induced airway hyperreactivity, oxidative stress, and lung inflammation. Newborn rats were exposed to hyperoxia (fraction of inspired oxygen - FiO2>95 % O2) or ambient air (AA) for seven days. Resveratrol was supplemented either in vivo (30 mg·kg-1·day-1) by intraperitoneal administration or in vitro to the tracheal preparations in an organ bath (100 mikroM). Contractile and relaxant responses were studied in tracheal smooth muscle (TSM) using the in vitro organ bath system. To explain the involvement of nitric oxide in the mechanisms of the protective effect of resveratrol against hyperoxia, a nitric oxide synthase inhibitor - Nomega-nitro-L-arginine methyl ester (L-NAME), was administered in some sets of experiments. The superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities and the tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) levels in the lungs were determined. Resveratrol significantly reduced contraction and restored the impaired relaxation of hyperoxia-exposed TSM (p<0.001). L-NAME reduced the inhibitory effect of resveratrol on TSM contractility, as well as its promotion relaxant effect (p<0.01). Resveratrol preserved the SOD and GPx activities and decreased the expression of TNF-alpha and IL-1beta in hyperoxic animals. The findings of this study demonstrate the protective effect of resveratrol against hyperoxia-induced airway hyperreactivity and lung damage and suggest that resveratrol might serve as a therapy to prevent the adverse effects of neonatal hyperoxia. Keywords: Bronchopulmonary dysplasia, Hyperoxia, Airway hyperreactivity, Resveratrol, Pro-inflammatory cytokines.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24009820
- 003
- CZ-PrNML
- 005
- 20250312151333.0
- 007
- ta
- 008
- 240606s2024 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.935239 $2 doi
- 035 __
- $a (PubMed)38710061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Reçica, R $u Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
- 245 10
- $a Protective Effects of Resveratrol Against Airway Hyperreactivity, Oxidative Stress, and Lung Inflammation in a Rat Pup Model of Bronchopulmonary Dysplasia / $c R. Reçica, I. Kryeziu, Q. Thaçi, D. Avtanski, M. Mladenov, M. Basholli-Salihu, RB. Sopi
- 520 9_
- $a Oxygen therapy provides an important treatment for preterm and low-birth-weight neonates, however, it has been shown that prolonged exposure to high levels of oxygen (hyperoxia) is one of the factors contributing to the development of bronchopulmonary dysplasia (BPD) by inducing lung injury and airway hyperreactivity. There is no effective therapy against the adverse effects of hyperoxia. Therefore, this study was undertaken to test the hypothesis that natural phytoalexin resveratrol will overcome hyperoxia-induced airway hyperreactivity, oxidative stress, and lung inflammation. Newborn rats were exposed to hyperoxia (fraction of inspired oxygen - FiO2>95 % O2) or ambient air (AA) for seven days. Resveratrol was supplemented either in vivo (30 mg·kg-1·day-1) by intraperitoneal administration or in vitro to the tracheal preparations in an organ bath (100 mikroM). Contractile and relaxant responses were studied in tracheal smooth muscle (TSM) using the in vitro organ bath system. To explain the involvement of nitric oxide in the mechanisms of the protective effect of resveratrol against hyperoxia, a nitric oxide synthase inhibitor - Nomega-nitro-L-arginine methyl ester (L-NAME), was administered in some sets of experiments. The superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities and the tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) levels in the lungs were determined. Resveratrol significantly reduced contraction and restored the impaired relaxation of hyperoxia-exposed TSM (p<0.001). L-NAME reduced the inhibitory effect of resveratrol on TSM contractility, as well as its promotion relaxant effect (p<0.01). Resveratrol preserved the SOD and GPx activities and decreased the expression of TNF-alpha and IL-1beta in hyperoxic animals. The findings of this study demonstrate the protective effect of resveratrol against hyperoxia-induced airway hyperreactivity and lung damage and suggest that resveratrol might serve as a therapy to prevent the adverse effects of neonatal hyperoxia. Keywords: Bronchopulmonary dysplasia, Hyperoxia, Airway hyperreactivity, Resveratrol, Pro-inflammatory cytokines.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a resveratrol $x farmakologie $7 D000077185
- 650 12
- $a oxidační stres $x účinky léků $7 D018384
- 650 12
- $a novorozená zvířata $7 D000831
- 650 12
- $a bronchopulmonální dysplazie $x prevence a kontrola $x metabolismus $7 D001997
- 650 12
- $a pneumonie $x prevence a kontrola $x metabolismus $x chemicky indukované $7 D011014
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a hyperoxie $x komplikace $x metabolismus $7 D018496
- 650 _2
- $a stilbeny $x farmakologie $x terapeutické užití $7 D013267
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a bronchiální hyperreaktivita $x prevence a kontrola $x metabolismus $x patofyziologie $x chemicky indukované $7 D016535
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a mužské pohlaví $7 D008297
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kryeziu, I
- 700 1_
- $a Thaçi, Q
- 700 1_
- $a Avtanski, D
- 700 1_
- $a Mladenov, M
- 700 1_
- $a Basholli-Salihu, M
- 700 1_
- $a Sopi, R B
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 73, č. 2 (2024), s. 239-251
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38710061 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y - $z 0
- 990 __
- $a 20240606 $b ABA008
- 991 __
- $a 20250312151340 $b ABA008
- 999 __
- $a min $b bmc $g 2283483 $s 1219650
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 73 $c 2 $d 239-251 $e 20240430 $i 1802-9973 $m Physiological research $n Physiol Res $x MED00003824
- LZP __
- $a Pubmed-20240606